Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001209191-20-056390)

Filing Details

Accession Number:: 0001209191-20-056390
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2020-11-02 14:00:55
Reporting Period:: 2020-10-29

Accepted Time:: 2020-11-02 14:00:55
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1750019	Tcr2 Therapeutics Inc.	TCRR	Biological Products, (No Disgnostic Substances) (2836)	474152751

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1760102	Robert Hofmeister	C/O Tcr2 Therapeutics 100 Binney Street Cambridge MA 02142	Chief Science Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2020-10-29	20,000	$0.74	58,850	No	4	M	Direct
Common Stock	Disposition	2020-10-29	20,000	$19.10	38,850	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (Right to Buy)	Disposition	2020-10-29	20,000	$0.00	20,000	$0.74

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
22,346	2018-12-07	2027-12-07	No	4	M	Direct

Footnotes

The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on by the reporting person.
25% of this option vested and become exercisable on December 7, 2018, with the remainder vesting in thirty-six (36) equal monthly installments thereafter.